{
    "Trade/Device Name(s)": [
        "MAS\u00ae PTH Control",
        "Moni-Trol\u00ae PTH Control"
    ],
    "Submitter Information": "Microgenics Corporation",
    "510(k) Number": "K092749",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043108"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "September 4, 2009",
    "Summary Letter Received Date": "September 8, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Parathyroid hormone (PTH)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        ""
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for MAS\u00ae PTH Control and Moni-Trol\u00ae PTH Control, liquid human serum-based controls for monitoring parathyroid hormone assay performance in clinical laboratories.",
    "Indications for Use Summary": "Intended for use in clinical laboratories as consistent test samples of known concentration to monitor assay conditions in various parathyroid hormone (PTH) determinations, providing expected ranges for assurance of reagent and instrument performance.",
    "fda_folder": "Clinical Chemistry"
}